Organization of primary care pathway in head and neck oncology (short version): Organization of chemotherapy in head and neck oncology - 07/09/15
, J. Guigay b, J. Lacau Saint-Guily c, C.-A. Righini dBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 4 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Chemotherapy may be indicated in head and neck cancer: as induction, associated with radiation therapy, or as a palliative solution, in case of local or locoregional progression if surgery and radiation therapy are contraindicated, and/or in case of metastatic progression. The most frequently used anticancer agents are platins, antimetabolites (5-fluorouracil, methotrexate) and taxanes. For several years now, in some indications, chemotherapy may be associated with targeted anti-EGFR antibody therapy. Prescription of chemotherapy and follow-up in head and neck cancer requires particular attention due to comorbidities related to alcohol abuse and smoking and frequent denutrition. Management thus requires close cooperation between the ENT physician, medical oncologists and radiation oncologists.
Le texte complet de cet article est disponible en PDF.Keywords : Chemotherapy, Targeted therapy, Head and neck, Care pathway
Plan
Vol 132 - N° 4
P. 209-212 - septembre 2015 Retour au numéro
Article précédent
- French Society of ENT (SFORL) guidelines for care pathway organization in head and neck oncology (short version). Early management of head and neck cancer
- F. Cuny, E. Babin, J. Lacau-Saint-Guily, B. Baujat, R. Bensadoun, A. Bozec, D. Chevalier, O. Choussy, S. Deneuve, N. Fakhry, J. Guigay, M. Makeieff, J.-C. Merol, F. Mouawad, J. Pavillet, C. Rebiere, C. Righini, M.-C. Sostras, M. Tournaille, S. Vergez, SFORL work group
- Guidelines (short version) of the French Otorhinolaryngology – Head and Neck Surgery Society (SFORL) on patient pathway organization in ENT: The therapeutic decision-making process
- S. Deneuve, E. Babin, J. Lacau-St-Guily, B. Baujat, R.-J. Bensadoun, A. Bozec, D. Chevalier, O. Choussy, F. Cuny, N. Fakhry, J. Guigay, M. Makeieff, J.-C. Merol, F. Mouawad, J. Pavillet, C. Rebiere, C.-A. Righini, M.-C. Sostras, M. Tournaille, S. Vergez
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?